+44 (0) 1223 755950
+1 832 327 7413
Orders to United States ship from United States
Target | BTB/POZ Domain-Containing Protein 9 (BTBD9) |
Clonality | Polyclonal |
Reactivity | Human |
Tested Applications | ELISA, WB, IHC, FCM |
Host | Rabbit |
Recommended dilutions | WB: 1/1000, IHC-P: 1/50 - 1/100, FCM: 1/10 - 1/50. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Immunogen | KLH-conjugated synthetic peptide between 237-262 amino acids from the Central region of human BTBD9. |
Isotype | IgG |
Form | Liquid |
Purification | Purified through a protein A column, followed by peptide affinity purification. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | Q96Q07 (UniProt, ExPASy) |
UniProt Secondary AC | Q494V9, Q494W1, Q96M00 |
UniProt Entry Name | BTBD9_HUMAN |
Gene Symbol | BTBD9 |
KEGG | hsa:114781 |
String | 9606.ENSP00000418751 |
Molecular Weight | Calculated MW: 69.2 kDa |
Buffer | PBS containing 0.09% sodium azide. |
Specificity | Predicted to react with Mouse, Rat and Cow BTBD9. |
Availability | Shipped within 5-10 working days. |
Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |